Monday April 28th, 2025
Defining the Difference for HS: SUNRISE and SUNSHINE: The Latest Chapter in the COSENTYX Story
W. Chad Cragun
MD
Please join us on Monday, April 28th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
In this 1-hour program, Chad Cragun, MD will present clinical data on COSENTYX, including insights on patient challenges, clinical trial results, and the legacy of COSENTYX in the Novartis commitment to dermatology
Thursday May 8th, 2025
Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK) in Pathophysiology, Unmet Needs, and Disease Burden
Marc Serota
MD
Please join us on Thursday, May 8th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
This presentation offers a revealing look at chronic spontaneous urticaria (CSU), centered on two key aspects: the role of Bruton’s tyrosine kinase (BTK) as a mediator of FcεRI mast cell degranulation in its pathophysiology, and the profound impact CSU symptoms can have on patients’ lives
Tuesday May 13th, 2025
Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway
Linda Stein Gold
MD
Please join us on Tuesday, May 13th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
Webinar Objectives: Review the evolving understanding of atopic dermatitis (AD), diagnosis, management, and the patient journey Evaluate a treatment option for mild to moderate AD Understand the indicated patient population for treatment
Tuesday May 27th, 2025
Invested in the Future of Derm
Jim Lee
PhD
Matteo Trotta
MBA
Please join us on Tuesday, May 27th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
Webinar Objectives: Recognize Incyte’s relentless pursuit to find answers for patients through strong science and R&D excellence Discover how Incyte is leveraging its unique legacy in drug development to pioneer a new era of dermatology treatments Understand how Incyte is committing to the future of dermatology through continued support and collaboration with patients and providers
Thursday May 29th, 2025
Clinical Updates for WINLEVI (clascoterone) Cream 1%
Hilary E. Baldwin
MD, FAAD
Please join us on Tuesday, May 27th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
Webinar Objectives: Recognize Incyte’s relentless pursuit to find answers for patients through strong science and R&D excellence Discover how Incyte is leveraging its unique legacy in drug development to pioneer a new era of dermatology treatments Understand how Incyte is committing to the future of dermatology through continued support and collaboration with patients and providers
Thursday June 5th, 2025
Vitiligo: Achieving and Maintaining Repigmentation
Seemal Desai
MD, FAAD
Please join us on Thursday, June 5th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
Webinar Objectives: Review clinical features of vitiligo, disease prevalence, treatment considerations, and the patient experience Discuss the mechanism of action and formulation for a topical treatment option for nonsegmental vitiligo Evaluate the safety and efficacy data for a topical treatment option in the treatment of nonsegmental vitiligo
PAST EVENTS
Tuesday April 15th, 2025
DANDRUFF DILEMMA: TREATMENT CHALLENGES, ROLE OF SCALP BARRIER, AND IMPORTANCE OF SCALP AND HAIRCARE IN OVERALL MANAGEMENT
Maria Hordinsky,
MD, FAAD
Heather Woolery-Lloyd
MD, FAAD
Please join us on Tuesday, April 15th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
Join us for our next CeraVe SkinChat Webinar: Dandruff Dilemma: Treatment Challenges, Role of Scalp Barrier, and Importance of Scalp and Haircare in Overall Management.
In this CeraVe SkinChat session, Maria Hordinsky, MD, FAAD, and Heather Woolery-Lloyd, MD, FAAD, will discuss the challenges of managing hair and scalp health, as well as the relationship between the scalp barrier and microbiome in patients with dandruff. They will also highlight new clinical research and innovative technologies that contribute to effective haircare solutions designed to support scalp health and help control dandruff.
Tuesday, January 28th 2025
Exploring Patient Burden and BTK-Driven Immune Dysregulation in CSU
Ellen Menefee
DMSc, MPAS
Please join us on Tuesday, Jan 28th, 2025 7:00PM- 8:00PM EDT for our next important webinar.
Chronic spontaneous urticaria (CSU) is a debilitating skin disorder associated with a high patient burden and impact on quality of life. Join us as we explore the current CSU treatment paradigm, unmet patient needs, and the role of Bruton's tyrosine kinase (BTK) in CSU
Thursday, October 10th 2024
Pfizer Dermatology Patient Access 2024
Leon Kircik
MD, FAAD
Shayli Nagelkerk
RMA, BC, PACS
Please join us on Thursday, Oct 10th, 2024 12:00PM- 1:00PM EDT for our next important webinar.
Please join us for our next IDEF Educational Series Webinar: Pfizer Dermatology Patient Access 2024 How to navigate the prescription journey for Litfulo and Cibinqo
Tuesday, October 1st 2024
Comorbidities in Psoriasis: From Psoriatic Arthritis to Obesity
Leon Kircik
MD, FAAD
Andrew F. Alexis
MD, MPH, FAAD
Brad Peter Glick
DO, MPH, FAAD
Saakshi Khattri
MD, MBBS, FAAD, FACR
Please join us on Tuesday, Oct 1st, 2024 7:00PM- 8:00PM EDT for our next important webinar.
In this presentation Drs. Andrew Alexis, Brad Glick, and Saakshi Khattri will explore key comorbidities associated with psoriasis with an aim to: - Explain the relationship between psoriasis and key comorbidities (obesity, cardiovascular disease, psoriatic arthritis, depression, and hepatic disease) - Explore the prevalence of these comorbidities in patients with psoriasis and their impact on patient burden - Recognize the clinical challenges in managing psoriasis patients with comorbidities and the role of the dermatologist
Tuesday, June 25th 2024
Optimizing Acne Patient Outcomes with Adjunctive Skincare Tailored for Diverse Patient Profiles
Brigitte Dréno
MD, PhD
Charles W. Lynde
MD, FRCPC, DABD, FCDA
Please join us on Tuesday, June 24th, 2024 12:30PM- 1:30PM EDT for our next important webinar.
Join us for a one-hour webinar with esteemed dermatologists Dr. Brigitte Dréno and Dr. Charles Lynde as they discuss the critical relationship between skin barrier integrity and acne. This session will cover patient characteristics that should be considered when treating acne and explore how adjunctive skincare tailored to diverse patients' needs recommendations can improve patient outcomes.